About Surmodics, Inc. 
Surmodics, Inc.
Pharmaceuticals & Biotechnology
Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.
Company Coordinates 
Company Details
9924 W 74th St , EDEN PRAIRIE MN : 55344-3523
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 47 Schemes (24.8%)
Foreign Institutions
Held by 68 Foreign Institutions (23.58%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Ms. Susan Knight
Non-Executive Independent Chairman of the Board
Mr. Gary Maharaj
President, Chief Executive Officer, Director
Mr. Jose Bedoya
Independent Director
Dr. David Dantzker
Independent Director
Ms. Lisa Heine
Independent Director
Mr. Ronald Kalich
Independent Director
Revenue and Profits:
Net Sales:
30 Million
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Pharmaceuticals & Biotechnology
USD 471 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.02
-5.99%
4.23






